3-O-beta-D-glucopyranosyl-(1→6)-[beta-D-glucopyranosyl-(1→2)]-[alpha-L-rhamnopyranosyl-(1→4)]-beta-D-glucopyranosyl-3beta,16beta,23,28-tetrahydroxyolean-12-ene - Compound Card

3-O-beta-D-glucopyranosyl-(1→6)-[beta-D-glucopyranosyl-(1→2)]-[alpha-L-rhamnopyranosyl-(1→4)]-beta-D-glucopyranosyl-3beta,16beta,23,28-tetrahydroxyolean-12-ene

Select a section from the left sidebar

3-O-beta-D-glucopyranosyl-(1→6)-[beta-D-glucopyranosyl-(1→2)]-[alpha-L-rhamnopyranosyl-(1→4)]-beta-D-glucopyranosyl-3beta,16beta,23,28-tetrahydroxyolean-12-ene

Structure
Zoomed Structure
  • Family: Plantae - Apiaceae
  • Kingdom: Plantae
  • Class: Saponin
    • Subclass: Triterpenoid Saponin
Canonical Smiles OCC1OC(OC2C(OC(C(C2O)OC2OC(C)C(C(C2O)O)O)COC2OC(CO)C(C(C2O)O)O)O[C@H]2CC[C@]3(C([C@]2(C)CO)CC[C@@]2(C3CC=C3[C@@]2(C)C[C@@H]([C@@]2(C3CC(C)(C)CC2)CO)O)C)C)C(C(C1O)O)O
InChI InChI=1S/C54H90O23/c1-23-33(60)36(63)40(67)46(71-23)76-43-28(20-70-45-39(66)37(64)34(61)26(18-55)72-45)74-48(44(42(43)69)77-47-41(68)38(65)35(62)27(19-56)73-47)75-32-11-12-50(4)29(51(32,5)21-57)10-13-52(6)30(50)9-8-24-25-16-49(2,3)14-15-54(25,22-58)31(59)17-53(24,52)7/h8,23,25-48,55-69H,9-22H2,1-7H3/t23?,25?,26?,27?,28?,29?,30?,31-,32-,33?,34?,35?,36?,37?,38?,39?,40?,41?,42?,43?,44?,45?,46?,47?,48?,50-,51-,52+,53+,54+/m0/s1
InChIKey JSRUYGJIRQTHGE-DSZRQXBZSA-N
Formula C54H90O23
HBA 23
HBD 15
MW 1107.29
Rotatable Bonds 13
TPSA 377.29
LogP -2.59
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 77
Formal Charge 0
Fraction CSP3 0.96
Exact Mass 1106.59
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Bupleurum spinosum Apiaceae Plantae 199135

Showing of synonyms

  • Dahmoune A, Smati D, et al. (2020). Triterpene saponins from the roots of Bupleurum spinosum Gouan. Phytochemistry Letters, 2020, 39, 157-161. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OCC2C(OC3CCCCO3)CC(OC4CCCCO4)C(O2)OC(CC5)CC(CC6)C5C(CC7)C6C(C=78)CCC9C8CCCC9

Level: 4

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OCC2CCC(OC3CCCCO3)C(O2)OC(CC4)CC(CC5)C4C(CC6)C5C(C=67)CCC8C7CCCC8

Level: 3

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OCC2C(OC3CCCCO3)CCC(O2)OC(CC4)CC(CC5)C4C(CC6)C5C(C=67)CCC8C7CCCC8

Level: 3

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(C6OC7CCCCO7)OCC(C6)OC8CCCCO8

Level: 3

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OCC2C(OC3CCCCO3)CC(CO2)OC4CCCCO4

Level: 3

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC(CC3)CC(CC4)C3C(CC5)C4C(C=56)CCC7C6CCCC7

Level: 2

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(OCCC6)C6OC7CCCCO7

Level: 2

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(OC6)CCC6OC7CCCCO7

Level: 2

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OCC2CCC(CO2)OC3CCCCO3

Level: 2

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OCC2C(CCCO2)OC3CCCCO3

Level: 2

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1OC2CC(COC2)OC3CCCCO3

Level: 2

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 1107.29 g/mol

Structure

SMILES: O1CCCCC1COC2CCCCO2

Level: 1

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 1107.29 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1107.29 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.65
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
645190.4
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
84319757.6

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.76
Plasma Protein Binding
13.27
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.22
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-1961079.4
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.84
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-153036289032.4
Rat (Acute)
3.81
Rat (Chronic Oral)
327.92
Fathead Minnow
193175565.91
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
17212334502.1
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-9561.26
Log(P)
-1.49
Log S
-2.15
Log(Vapor Pressure)
-566793358.99
Melting Point
222.33
pKa Acid
-4129881.61
pKa Basic
-33216.58

No predicted protein targets found for this compound.

Download SDF